isoxazoles has been researched along with bromodeoxyuridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arshad, F; Bailey, SC; Kurtz, ES; Lee, AA; Przekop, PA | 1 |
| Chun, J; Fukushima, N; Moriyama, R; Shano, S | 1 |
2 other study(ies) available for isoxazoles and bromodeoxyuridine
| Article | Year |
|---|---|
Leflunomide: an active antiinflammatory and antiproliferative agent in models of dermatologic disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bromodeoxyuridine; Cell Division; Chronic Disease; Edema; Humans; Isoxazoles; Leflunomide; Leukotriene B4; Male; Mice; Mice, Inbred Strains; Neutral Red; Peroxidase; Phorbol Esters; Skin Diseases | 1995 |
Lysophosphatidic acid stimulates neuronal differentiation of cortical neuroblasts through the LPA1-G(i/o) pathway.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Separation; Cells, Cultured; Cerebral Cortex; Female; Immunohistochemistry; In Situ Nick-End Labeling; Isoxazoles; Lysophospholipids; Mice; Mice, Inbred ICR; Neurons; Pregnancy; Propionates; Receptor, Platelet-Derived Growth Factor alpha; Tubulin | 2007 |